Johnson & Johnson Stock News

Johnson & Johnson's business generated modest single-digit growth last quarter. The drugmaker announced it will be raising its dividend for a 62nd consecutive year.

Looking for long-term stocks to buy for decades of gains requires a strategy focusing on stable, established companies with proven track records. The key to selecting long-term stocks to buy to build

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?

Five stocks to focus with recent dividend hike are: JNJ, TRV, SON, KBH, SPFI.

Investors don't have to look far to find justification for investing in dividend aristocrats. Generally speaking, dividends are an excellent way to secure stable returns and compound one's wealth.

Bert's March Dividend Income Summary

In the changing environment of 2024, astute investors have a plethora of options to strengthen their financial portfolios strategically by purchasing dividend stocks. These prospects result from i

Altria offers an outsized dividend with little risk of a cut. Johnson & Johnson isn't flashy, but it's a bargain you shouldn't pass up.

Stocks like KB Home (KBH), Interactive Brokers Group, Inc. (IBKR), QUALCOMM Incorporated (QCOM) and Johnson & Johnson (JNJ) recently hiked dividends.

Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

An Illinois court late Friday ordered pharmaceutical giant Johnson & Johnson and Kenvue to pay $45 million to a family that alleged the companies' talcum-based baby powder led to the death of a relati

Focusing on consistent dividend growth can lead to higher returns in lower-risk areas. The portfolio emphasizes companies with wide-moat business models, strong financials, and a commitment to shareho

With continued volatility in the stock market right now, it's no wonder investors are looking for stocks with proven track records to bolster their portfolios. While U.S. stocks opened strong on Monda

The World Health Organization is likely to issue a wider warning about contaminated Johnson and Johnson-made children's cough syrup found in Nigeria last week, it said in an email.

Johnson & Johnson (NYSE: JNJ) recently reported its Q1 results, with revenues marginally below but earnings exceeding our estimates. The company reported revenue of $21.4 billion and adjusted earnings